Diffuse Parenchymal Lung Disease Flashcards

1
Q

How is small fiber neuropathy due to sarcoid treated?

A

Fells pain, paresthesias, numbness, and burning sensations. Can be resistant to standard immunosuppressive treatment including steroids and methotrexate. IVIG and anti-TNF can be beneficial. Can also try amitriptyline, gabapentin, or carbamazepine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the CT findings of chronic hypersensitivity pneumonitis?

A

Mosaic attenuation, diffuse centrilobular nodular opacities, and GGOs with lung bases spared

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the features of silicosis?

A

Histo: non-necrotizing granulomas, multinucleated giant cells with cytoplasmic inclusions (asteroid bodies), silicotic nodule with whorled hyalinized collagen, polarized microscopy shows faintly birefringent particles within fibrotic nodules
Features: drilling/sandblasting/rock quarry, can take decades to develop symptoms. Has increased risk of developing cancer
Imaging: innumerable upper lobe predominant small rounded nodules with perilymphatic distribution, hilar/mediastinal LAD, eggshell calcification of LNs, can be PET avid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some genes associated with lung diseases?

A

Familial pulmonary fibrosis- TERT/TERC, SFTPC, MUC5B, RTEL1, TOLLIP
Birt-Hogg-Dube-FLCN (chromosome 17p11.2) tumor suppressor gene folliculin
Tuberous sclerosis/LAM- TSC1 and TSC2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the features of silicone embolism syndrome?

A

Histo- clear vacuoles containing translucent refractile, nonbirefringement microdroplets within and adjacent to alveolar septal capillaries surrounded by histiocytes
Features- right heart failure, ARDS, ILD
Imaging- disruption of implant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is scleroderma ILD best treated?

A

MMF to improve FVC, equal benefit from cyclophosphamide but more than 12m of treatment had serious SE. Only have data on nintedanib helping slow progression of FVC loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the features of pulmonary alveolar microlithiasis?

A

Histo- rarely needed
Features- Dx in early adulthood, autosomal recessive
Imaging- Sandstorm on CXR, CT with micronodular calcification along bronchovascular bundles and subpleural regions
Dx- Usually just imaging, BAL may show lamellar microliths
Tx- supportive, lung transplant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are risk factors for increased in-hospital mortality for surgical lung biopsies?

A

Male, increasing age, high comorbidity scores, open vs VATS, “provisional” Dx IPF/CT-ILD. 6.4%. Cryobiopsy is now deemed an acceptable alternative to surgical lung biopsy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are some definite histopathologic findings for UIP pattern?

A

dense fibrosis/architectural distortion +/1 honeycombing, patchy involvement, fibroblast foci, subpleural/paraseptal predominance, no features suggesting an alternative Dx such as granulomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Remember chart for radiologic and histologic UIP patterns and their likelihood of being IPF

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the benefit of inhaled treprostinil in CT-ILD related PH?

A

Increased 6MWT, no change in QOL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How is progressive pulmonary fibrosis defined?

A

ILD other than IPF AND 2/3 of the following within the past year without explanation: 1) worsening symptoms 2) physiologic progression (absolute 5% decline FVC or absolute 10% decline in DLCO), 3) radiologic progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the indications for antifibrotics?

A

Nintedanib- IPF, SSc0ILD, chronic fibrosing ILD with progressive phenotype (PPF)

Pirfenidone- IPF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the common radiologic finding in CPFE?

A

Upper lobe emphysema and lower lobe fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the most common radiologic pattern of fibrosis in CT-ILD?

A

NSIP, except in RA-ILD (UIP pattern is most common) but will often get tested in seeing LIP in Sjogren’s despite NSIP still being more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What type of lymphoma is most often seen in patient’s with Sjogren’s?

A

MALTomas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the features of antisynthetase syndrome?

A

Features: subset of PM/DM, “mechanics hands”, acute onset, Raynaulds, difficult to treat
Dx: anti-Jo, aminoacyl-tRNA synthetase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the treatments for CT-ILDs?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the features of sarcoidosis?

A

Features: most common in AA, women, familial clusters, 20-60 on presentation with 90% of patients with lung involvement, wheezing if airway involvement, rare clubbing, some extrapulmonary involvement including eyes, cardiac, skin, calcium, nervous system, LNs
Imaging: hilar/mediastonal LAD, nodules along bronchovascular bundle, upper lobe traction broncheictasis and fibrosis, perilymphatic nodules
Dx: noncaseating granulomas in Bx, lymphocytic BAL (15+%), high CD4/CD8 ratio
Staging: 0= no lung involvement, 1= bilateral hilar LAD, 2= bilat hilar LAD + parenchymal, 3= parenchymal without hilar LAD, 4= progressive fibrosis +/- cavity/cysts
Tx: treat symptomatic stage II/III with PFT impairment or progression or with extrapulmonary involvement with pred 20-40mg/d (40-60 in cardiac) for 4-6w then taper over 6-12 mo, alt. MTX, AZA, Leflunomide, TNF antagonist, transplant. For cough in mild I/II, try ICS. Can have spontaneous remission in all but stage IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the features of granulomatous lymphocytic ILD?

A

Features: ILD with non-necrotizing granulomas, LIP, and follicular bronchiolitis. In patients with immunodeficiency, often CVID, 20-50yo, DOE/cough, or asymptomatic
Imaging: GGO, nodules, LAD
Dx: usually sugrical lung Bx
Tx: IVIG, steroids, immunosuppression/RTX

21
Q

What are the features of follicular bronchiolitis?

A

Histo: reactive lymphoid follicles with germinal centers around bronchi/bronchioles
Features: can occur independently or with autoimmune disorders, middle aged, gradual onset, fever and weight loss
Imaging: bilat centrilobular nodules and patchy GGOs
Dx: surgical lung biopsy as TBBx cannot provide enough tissue, distinguish from lymphoma as can occur frequently in Sjogrens
Tx: immunosuppressive drugs, some case reports with macrolides

Of note: differentiated from LIP as it has diffuse interstitial and alveolar septal infiltration of lymphocytes

22
Q

What are the features of cryptogenic organizing pneumonia?

A

Histo: endoluminal granulation tissue polyps (Masson bodies), type II pneumocyte metaplasia
Features: idiopathic or associated with infection, autoimmune, IBD, transplant, drug, environment. Cough, fever, malaise, weight loss
Imaging: patchy lower lung predominant consolidation and GGO with subpleural/peribrocnhovascular distribution. Bilateral, peripheral, and migratory. can also have atoll sign.
Dx: biopsy
Tx: prednisone .75-1mg/kg/day with gradual tapering over 6-12 months

23
Q

What are the features of pulmonary benign metastasizing leiomyoma?

A

Histo: uterine well-differentiated spindle shaped cells
Features: rare, women of late childbearing age with Hx uterine leiomyomas, cough, dyspnea, PTX/hemothorax, hemoptysis
Imaging: numerous random, well-circumscribed nodules with miliary pattern, can cavitate, low/no avidity on PETCT
Dx: biopsy

24
Q

What is the most important factor in considering daptomyosin associated AEP?

A

Duration of therapy- mean onset being 2.8 weeks. Dramatic response to steroids (2-4w). Avoid future exposures

25
Q

What are the features of Kartagener syndrome?

A

Triad of situs inversus, chronic sinusitis, and bronchiectasis, as subgroup of PCD

26
Q

Describe the diagnostic guidelines for hypersensitivity pneumonitis

A

BAL lymphocytes more than 30%, positive antigens, three density pattern on CT, centrilobular GGO, head cheese sign on imaging for fibrosing HP, cryobiopsy has greater yield but may not always be necessary, low CD4/CD8 ratio

27
Q

What are the features of idiopathic inflammatory myositis?

A

Histo:
Features: fever, rash, proximal muscle weakness, dysphagia
Imaging: patchy GGOs
Dx: elevated CRP, aldolase, PL-7 antisynthetase antibody, Ro antibody, ANA often negative
Tx: steroids, immunosuppression

28
Q

Why are there so few patients with advanced pulmonary sarcoidosis receiving lung transplant?

A

Likely due to the higher mortality. Will also exhibit higher PGD, 30 day mortality, prolonged ventilation/LOS but with similar long-term outcomes and median survival

29
Q

What treatment options are there for PAP?

A

Previously only whole lung lavage, but now nebulized GM-CSF augmentation has proved to improve DLCO, CT findings, and dyspnea. Testing for GM-CSF antibodies are both sensitive and specific, and serum GM-CSF is usually normal

30
Q

Match CT findings of ILD with histology

A
31
Q

What are the features of bleomyocin toxicity?

A

Risks: older age, cumulative dose, renal dysfunction, previous/synchronous radiation, high supplemental oxygen, GCSF.

1-6 months after treatment, bilateral reticular/interstitial opacities with GGOs, fibrosis over time

Treat with 1mg/kg of prednisone and taper over several months

32
Q

What are the features of dermatomyositis associated ILD?

A

Features: hyperkeratosis, periungual erythema with dilated nail fold capillaries, fever, minimal myopathy
Dx: anti-MDA5

33
Q

What are the features of pulmonary lymphomatoid granulomatosis?

A

Histo: polymorphic lymphocytic infiltrate, angiitis, central necrosis
Features: mid age, male predominance, cough, dyspnea, fevers, malaise, weight loss, hemoptysis with cavitation, skin papules in glutes and extremities, low level EBV viremia in immunosuppressed patients
Imaging: peribronchovascular nodules, coarse irregular opacities, small cysts, cavitary masslike opacities that wax and wane over time
Dx: surgical lung biopsy, grade 1-3 based on amount of lymphocytes
Tx: stop triggering immunosuppressive medication, RTX with grade 3 disease

34
Q

Other than lung transplant, what conditions are associated with constrictive/obliterative bronchiolitis?

A

Inhalational injury, infections, systemic disease, hematopoietic transplant

35
Q

How can refractory chronic eosinophilic pneumonia be treated?

A

High dose ICS, omalizumab, mepolizumab, benralizumab, and dupilumab have been tried. Unfortunately relapse is common

36
Q

Why would you choose pirfenidone over nintedanib?

A

Nintedanib is metabolized by CYP3A4, can’t use with other CYP3A4 inducers (carbamazepine, phenytoin, St John’s wart)

37
Q

Describe testicular nodules in GU sarcoidosis

A

Nontender, discrete and palpable. Can have coexisting sarcoid and cancer so still need testicular biopsy.

38
Q

What are some additional therapies for ICI pneumonitis that is not responding to steroids?

A

Infliximab, cyclophosphamide, MMF

39
Q

What are the stages of ABPA?

A

Stage I- acute (elevated IgE, asthma, eosinophilia, opacities, antibodies), Stage II- remission, stage III- exacerbation, Stage IV- steroid dependent asthma, stage V-fibrosis

40
Q

How is ABPA treated?

A

Steroids, +/- itraconazole for 16 weeks (vori has been used), limited evidence for omalizumab, standard asthma treatment

41
Q

What are some of the more common triggers od drug induced AEP?

A

Daptomycin, NSAIDs, amiodarone, MTX, cocaine/heroin inhaled (over 140+ medications reported)

42
Q

What are the features of idiopathic AEP?

A

Histo: diffuse alveolar damage, eosinophils
Features: young and healthy, recent smoking, WTC, vaping, febrile illness of 5-7d can rapidly progress
Imaging: diffuse alveolar or mixed alveolar and interstitial opacities
Dx: BAL eos >25%, peripheral eos not present early on
elevated BAL IL5/VEGF/IL18, serum IgE
Tx: steroids 2-8w, relapse is rare

43
Q

What are the features of chronic eosinophilic pneumonia?

A

Histo: eos, BO, microabscesses, or noncaseating granulomas
Features: middle aged women, 1/2 with asthma, subacute to chronic presentation with fever, night sweats, weight loss, cough and wheezing, high peripheral eos above 30%
Imaging: peripheral based opacities, “photographic negative of pulmonary edema” but seen in less than 1/2 patients
Dx: BAL high, elevated IgE
Tx: steroid for 3-6 months with frequent relapse

44
Q

What are the features of idiopathic hypereosinophilic syndrome?

A

Features: young to middle aged males, multisystem syndrome with also cardiac/skin/GI/neuro involvement
Dx: unexplained Eos 1500 for more than 6 months or 2 exams more than 1 month apart PLUS some sign of end organ dysfunction
Tx: steroids, IFN-alpha, chemo, hydroxyurea, imatinib

45
Q

What are the features of EGPA?

A

Histo: necrotizing eosinophilic vasculitis, granulomas
Features: middle age, subacute (3 phases- asthmatic–>eosinophilic–>vasculitic), mononeuritis multiplex, sinus disease, skin involvement in 1/2, DAH is rare (less than 5%), cardiomyopathy in 12%, P-ANCA in 40-60% and may correlate with vasculitis, controversy if LTRAs cause versus unmask
Dx: 4/6 criteria: asthma, eosinophilia, paranasal sinus abnormalities, mononeuropathy, migratory pulm opacities, extravascular eos on biopsy
Tx: steroids, maintenance with RTX, AZA, MTX, leflunomide, mepo. Relapse is uncommon, refractory can try cyclophosphamide, plasmaphoresis

46
Q

What are the features of pulmonary Langerhans cell histiocytosis?

A

Histo: bronchocentric destructive Langerhans cells (CD1a, langerin, S100)
Features: young adult smokers, can have PTX, bone lesions in 10%, rarely DI
Imaging: irregular cysts, basilar sparing, nodules +/- cavitation, reticular opacities
Dx: imaging, BAL >5% CD1a cells, TBBx
Tx: smoking cessation, BRAF inhibitors if patient has BRAF-V600E mutation, cobimetinib, cladribine, cytarabine, MTX, can be used, screen for PH, lung Tx. Has increased risk of malignancy

47
Q

Which tumors should patients with Birt-Hogg-Dube syndrome be screened for?

A

Renal tumors. Will also have fibrofolliculomas which are benign

48
Q

What are the characteristics of the cysts seen in Birt-Hogg-Dube syndrome?

A

Varying sizes and shapes, favoring medial and lower lung fields